Benzinga's Top Upgrades, Downgrades For December 29, 2016 - Texas Instruments (NASDAQ:TXN), Anthera Pharmaceuticals (OTC:ANTH)

Jefferies downgraded Anthera Pharmaceuticals Inc ANTH from Buy to Hold. The price target for Anthera Pharma has been lowered from $5 to $1. Anthera Pharma shares rose 6.33 percent to $0.789 in pre-market trading.
Citigroup downgraded Anthera Pharmaceuticals Inc ANTH from Buy to Neutral. Anthera Pharma shares rose 6.33 percent to $0.789 in pre-market trading.

Analysts at Summit Redstone Partners initiated coverage on Texas Instruments Incorporated TXN with a Buy rating. The price target for Texas Instruments is set to $84. Texas Instruments shares closed at $74.05 on Wednesday.
Analysts at Cantor Fitzgerald initiated coverage on Senior Housing Properties Trust SNH with an Overweight rating. The price target for Senior Housing Properties Trust is set to $23. Senior Housing Properties Trust shares closed at $18.09 on Wednesday.
Northland Capital Markets initiated coverage on Intrexon Corp XON with an Outperform rating. The price target for Intrexon is set to $40. Intrexon shares closed at $24.54 on Wednesday.